United Therapeutics Corp (UTHR)

Finanzdaten der United Therapeutics Corp-Aktie (UTHR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.87% 614.70	609.40	596.50	506.90	491.50
Cost Of Revenue	1.28% 71.00	70.10	64.10	52.30	58.80
Gross Profit	0.82% 543.70	539.30	532.40	454.60	442.70
Operating Expenses	33.58% 283.60	212.30	219.00	170.20	267.10
Interest Income/Expense	3.21% 15.10	15.60	14.80	13.80	12.30
Benefits Costs and Expenses	23.95% 319.30	257.60	261.30	215.00	312.70
Costs And Expenses	25.57% 354.60	282.40	283.10	222.50	315.90
Operating Income/Loss	20.46% 260.10	327.00	313.40	284.40	175.60
Nonoperating Income/Loss	42.34% 35.30	24.80	21.80	7.50	3.20
Income/Loss From Continuing Operations Before Tax	16.03% 295.40	351.80	335.20	291.90	178.80
Income Tax Expense/Benefit	7.01% 78.30	84.20	76.00	51.00	46.70
Income/Loss From Continuing Operations After Tax	18.87% 217.10	267.60	259.20	240.90	132.10
Net Income/Loss	18.87% 217.10	267.60	259.20	240.90	132.10
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.79% 0.10	46.90	46.90	46.30	0.20
Diluted Average Shares	99.80% 0.10	49.70	49.50	49.60	0.30
Basic Earnings Per Share	19.44% 4.60	5.71	5.53	5.20	2.84
Diluted Earnings Per Share	19.52% 4.33	5.38	5.24	4.86	2.65
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-